Diabetes, Vol 38, Issue 9 1142-1147, Copyright © 1989 by American Diabetes Association

ARTICLES

Mean glomerular volume and rate of development of diabetic nephropathy

RW Bilous, SM Mauer, DE Sutherland and MW Steffes
Department of Laboratory Medicine, University of Minnesota Medical School, Minneapolis.

We studied kidney glomerular structure and function in two groups of type I (insulin-dependent) diabetic subjects with 14-16 yr (group 1, n = 16) and 24-26 yr (group 2, n = 13) duration of diabetes and compared them to a group of 18 nondiabetic subjects with similar age ranges. Within each diabetic group, subjects were selected for normal kidney function (urinary albumin excretion less than 40 mg/24 h, normal blood pressure, creatinine clearance greater than 90 ml.min-1.1.73 m-2) or for nephropathy (urinary albumin excretion greater than 200 mg/24 h). Morphometric analysis of glomeruli revealed a significantly larger mean glomerular volume in subjects with nephropathy (group 2). Mesangial volumes were significantly greater in the nephropathic than the normoalbuminuric diabetic subjects in each group, but filtration surface per glomerulus was constant among all subjects. The percentage of sclerosed glomeruli was also significantly increased in the nephropathic subjects compared with the subjects with normal kidney function, in whom sclerosed glomeruli did not exceed 8%. In addition, there was a significant correlation between percentage of globally sclerosed glomeruli and glomerular volume in group 2 (rs = .79, P less than .01) but not group 1 (rs = -.20, NS) subjects. Thus, glomerular size or individual capacity for glomerular expansion may determine the rate of progression of the loss of kidney function in subjects destined to develop diabetic nephropathy.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. Guo, D. Martinez-Vasquez, G. P. Mendez, M. F. Toniolo, T. M. Yao, E. M. Oestreicher, T. Kikuchi, N. Lapointe, L. Pojoga, G. H. Williams, et al. Mineralocorticoid Receptor Antagonist Reduces Renal Injury in Rodent Models of Types 1 and 2 Diabetes Mellitus Endocrinology, November 1, 2006; 147(11): 5363 - 5373. [Abstract] [Full Text] [PDF]

				W. E. Hoy, T. Samuel, M. D. Hughson, J. L. Nicol, and J. F. Bertram How Many Glomerular Profiles Must Be Measured to Obtain Reliable Estimates of Mean Glomerular Areas in Human Renal Biopsies? J. Am. Soc. Nephrol., February 1, 2006; 17(2): 556 - 563. [Abstract] [Full Text] [PDF]

				Y. Gorin, K. Block, J. Hernandez, B. Bhandari, B. Wagner, J. L. Barnes, and H. E. Abboud Nox4 NAD(P)H Oxidase Mediates Hypertrophy and Fibronectin Expression in the Diabetic Kidney J. Biol. Chem., November 25, 2005; 280(47): 39616 - 39626. [Abstract] [Full Text] [PDF]

				T. Samuel, W. E. Hoy, R. Douglas-Denton, M. D. Hughson, and J. F. Bertram Determinants of Glomerular Volume in Different Cortical Zones of the Human Kidney J. Am. Soc. Nephrol., October 1, 2005; 16(10): 3102 - 3109. [Abstract] [Full Text] [PDF]

				D. Feliers, M. A. Frank, and D. J. Riley Activation of Cyclin D1-Cdk4 and Cdk4-Directed Phosphorylation of RB Protein in Diabetic Mesangial Hypertrophy Diabetes, November 1, 2002; 51(11): 3290 - 3299. [Abstract] [Full Text] [PDF]

				B. Najafian, J. M. Basgen, and M. Mauer Estimating Mean Glomerular Volume Using Two Arbitrary Parallel Sections J. Am. Soc. Nephrol., November 1, 2002; 13(11): 2697 - 2705. [Abstract] [Full Text] [PDF]

				T. S. Kern and R. L. Engerman Pharmacological Inhibition of Diabetic Retinopathy: Aminoguanidine and Aspirin Diabetes, July 1, 2001; 50(7): 1636 - 1642. [Abstract] [Full Text] [PDF]

				K. E. WHITE and R. W. BILOUS Type 2 Diabetic Patients with Nephropathy Show Structural--Functional Relationships that Are Similar to Type 1 Disease J. Am. Soc. Nephrol., September 1, 2000; 11(9): 1667 - 1673. [Abstract] [Full Text]

				J. M. Macleod, K. E. White, H. Tate, and R. W. Bilous Measurement of glomerular volume in needle biopsy specimens Nephrol. Dial. Transplant., February 1, 2000; 15(2): 239 - 243. [Abstract] [Full Text] [PDF]

				J. Megyesi, P. M. Price, E. Tamayo, and R. L. Safirstein The lack of a functional p21WAF1/CIP1 gene ameliorates progression to chronic renal failure PNAS, September 14, 1999; 96(19): 10830 - 10835. [Abstract] [Full Text] [PDF]

				J. R. NYENGAARD Stereologic Methods and Their Application in Kidney Research J. Am. Soc. Nephrol., May 1, 1999; 10(5): 1100 - 1123. [Abstract] [Full Text]

				D. M. Nathan Long-Term Complications of Diabetes Mellitus N. Engl. J. Med., June 10, 1993; 328(23): 1676 - 1685. [Full Text]